Lercanidipine

Chemical formula: C₃₆H₄₁N₃O₆  Molecular mass: 611.727 g/mol  PubChem compound: 65866

Therapeutic indications

Lercanidipine is indicated for:

Mild to moderate essential hypertension

Population group: only adults (18 years old or older)

Lercanidipine is indicated for the treatment of mild to moderate essential hypertension.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Lercanidipine is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Left ventricular outflow tract obstruction

LVOTO - Left ventricular outflow tract obstruction

Untreated congestive cardiac failure

Congestive heart failure

Unstable angina pectoris

Preinfarction syndrome

Within 1 month of a myocardial infarction

at least one of
Recent myocardial infarction
Myocardial infarction

Severe renal impairment

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Severe hepatic impairment

Hepatic failure stage IV

Inhibitors of CYP3A4

CYP3A4 inhibitors

Ciclosporin

Ciclosporin

Grapefruit

Grapefruit

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2021: ZANIDIP Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈